Isotonic milk replacer additives help piglets overcome critical productivity hurdles
DUBLIN, IRELAND–(Newsfile Corp. – 21 November 2022) – Tonisity International Limited (“Tonicity”), an Ireland-based animal health and nutrition company, is pleased to announce the launch of Tonisity PxM (PxM), which will help piglets overcome a major productivity hurdle. An isotonic milk replacer additive that helps in.PxM is the third product in Tonisity’s proprietary isotonic beverage range to enhance pig production.
About Tonisity PxM
Tonisity PxM is a bioactive pack specially formulated to be mixed with milk replacer, which is widely used in farrowing pens to supplement sow’s milk. PxM includes Tonisity’s gut-enhancing bioactives in a formula compatible with milk replacer and Tonisity Px, Tonisity’s pre-existing swine product focused on the calving and weaning stages of piglets. Highly complementary to ® and Tonisity PxW®.
Tonicity PxM
To view an extended version of this graphic, please visit:
https://images.newsfilecorp.com/files/8645/145069_b5f561d5d492789f_002full.jpg
Administering PxM on the farm is very easy. Simply mix with milk replacer in your farm’s existing delivery system. The Tonisity PxM is flexible because it is designed to fit your farm’s milk replacer dosing schedule. Only 0.5% PxM is required in milk replacer.
In a recent study on a 400 sow farm in Eastern Europe, 17 days of treatment with Tonisity PxM resulted in a 51% reduction in preweaning mortality and +36 more piglets per 1,000 live births. rice field.[1] Additionally, pigs gained an additional weaning weight of 220 grams.[2]which gives the farm an 11:1 return on investment.
The Tonisity PxM was announced at the EuroTier trade fair in Hannover, Germany on November 15th.thEuroTier is the leading international trade fair for professional animal husbandry and livestock management. Tonisity plans to begin selling Tonisity PxM to milk replacer customers in December 2022.
Tonisity International Managing Director Mathieu Cortyl commented: Great return on investment for our customers. We are proud to add another cutting edge product to our suite of isotonic swine products.
Mihai Condu, manager of Agromar farm in Romania, who conducted the PxM evaluation, commented: The benefits of Tonisity’s bioactives were immediate. Piglets drank better milk replacer and were more active. Tonisity PxM allows us to provide additional support to the intestines of these young piglets. As a result, we are able to sell more, better quality and healthier piglets. You can. This is the biggest improvement our team has ever seen.
Tonisity’s line of gut enhancement products improve pig survival. Especially during the first month of life, up to 15% of piglets die, mainly from malnutrition and intestinal health problems. Improved piglet survival and improved pre- and post-weaning performance allows producers to bring their pigs to market with a return on investment of up to 5-10x. These benefits are especially important in times of African swine fever, with increased labor and feed costs.
For more information on Tonisity, visit
Tonisity is an Ireland-based animal health and nutrition company that currently focuses its patented technology on two specific markets. (2) new companion animal nutrition products; Tonisity focuses on creating positive physiological changes by addressing gut health issues in young animals. With new companion animal products, Tonisity is poised to be the pioneer and market leader in targeted nutritional approaches for pets, a rapidly growing market worldwide. For more information on Tonisity’s isotonic business, please visit www.tonisity.com. For more information on Tonisity’s companion animal business, please visit www.doggyrade.com.
On behalf of the Board of Directors
“Allie Halpern”
Allie Halpern
representative
Email: arie@tonisity.com
Forward-Looking Statements
This press release contains forward-looking statements and information that are based on management’s beliefs and reflect Tonisity’s current expectations. As used in this press release, “estimate”, “predict”, “believe”, “expect”, “intend”, “expect”, “plan”, “predict”, “possible” The words “may” or “should” and negative forms of these words or variations thereof or equivalent terms are intended to identify forward-looking statements and information. .
Forward-looking statements and information in this press release include information regarding Tonisity’s business plans, including the development of new product lines in both the swine and companion animal product lines.
Such statements and information reflect Tonisity’s current views. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, or other Future events may differ materially from any future results, performance or achievements expressed or implied by us. such forward-looking statements. Such factors include, among others, the risks of: Tonisity’s ability to raise capital to sustain its growth and business objectives; the geographic markets that Tonisity has negotiated and are part of its expansion plans; changes in laws and regulations that may adversely affect Tonisity’s business, growth or results of operations; Tonisity’s ability to attract and retain customers and consumers; Impact of the COVID-19 pandemic.
There are several important factors that could cause Tonisity’s actual results to differ materially from those indicated or implied by the forward-looking statements and information. Such factors include, among others: risks associated with Tonisity’s corporate strategy, including the failure of past and future acquisitions to meet expectations; disruptions or changes in the credit or securities markets; results of operational activities; unexpected costs and expenses, commodity price fluctuations and general market and industry conditions; Protection of Tonisity Intellectual Property. Disruption at any of Tonisity’s facilities, including as a result of the current COVID-19 pandemic. Impact of public health crises, including the current COVID-19 pandemic. Tonisity Supply Chain Management. availability of raw material suppliers; limited or interrupted supply of key raw materials; Availability of key ingredients in Tonisity’s products. Failure to expand production capacity. effects of product innovation; failure to retain existing customers and/or acquire new customers; potential volatility in stock prices; There is no guarantee of an active market for stocks. dividends; global financial conditions; impact of product labeling requirements; raw material prices; consumer trends; Control and Conflicts of Interest.
Tonisity warns that the list of key factors above isn’t exhaustive. Readers should carefully consider the aforementioned factors and other uncertainties and potential events when making decisions based on Tonisity’s forward-looking statements and information. Tonisity does not expect such forward-looking statements or information to differ materially from actual results or events due to the important factors referred to in the preceding paragraph. However, this list of factors is not exhaustive, is subject to change, and there is no guarantee that such assumptions will reflect the actual results of such items or factors.
The forward-looking information contained in this press release represents Tonisity’s expectations as of the date of this press release and is therefore subject to change after that date. Readers should not place undue weight on forward-looking information or rely on this information as of any other date. Tonisity reserves the right to choose, but makes no commitment to update this information at any particular time, except as required by applicable law.
[1] N=398 piglets, *P=0.08.
[2] P = 0.28 – 306 liters are required for the difference to be significant with P < 0.05.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/145069.
